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1063-l 5 Residual Atriai Septai Defect Following Dual 
Transseptai Catheterization: A Doppler Color Flow 
Imaging Follow-Up 
Jian-Fang Ren, Francis E. Marchlinski, David J. Callans. University of Pennsylvania, 
Philadelphia, PA 
We have observed that dual transseptal catheterization (TC) causes atrial septal defect 
(ASD) with interatrial shunt after withdrawal of catheters following LA ablation procedure. 
The present study characterized the magnitude, time wurse and regression of this resid- 
ual ASD using AcuNav diagnostic ultrasound catheter with Doppler color flow imaging 
immediately after TC and at repeat ablation. Methods and Fteeufts: The study included 
47 pts (40 men; age 56rlO yrs) with atrial fibrillation (AF) undergoing dual TC (two 8 Fr 
Mullins sheaths, TC duration 225+40 min) and AF ablation. In 23 pts we assessed acute 
ASD size immediately after TC removal (3.5+0.7mm) and at Pmin (2.9*0.6mm), 4min 
(2.8+0.5mm), 6min (2.5*0.7mm), 10min (2.420.7mm) and 15-30min (2.4a0.6mm) after 
TC. There was significant reduction of ASD size within 6min (~~0.05) immediately after 
TC. In remaining 24 pts with repeat ablation for recurrent AF (at 4.8~3.7 months) with 43 
residual ASD at end of first procedure, assessment for residual ASD Pre-repeat TC was 
performed. Residual ASD was detected in 2/2 at 3 days, 5119 at 1 to 3 months, 6/12 at 4 
to 6 months and O/l0 at 7 to 17 months (Table). No residual ASD (35146, 76%) was 
detected with follow-up (l-17 months). Conclusions: Residual ASD after TC appears to 
reduce in Size (all < 4 mm) during follow-up and may resolve compltely by 7 months. 
Table. Follow-up changes in residual ASD size 
Initial Residual 3 days 1-3months 4.6months 7-l 7months 
ASD(mm) 2.6i0.6 3.liO.3 1.4*0.4 1.5+0.7 0 
Range(mm) 1.6-3.9 2.9 & 3.3 0.8-1.9 0.8-2.6 0 
1063-16 Occurrence of Transient ST-Segment Elevation During 
Pulmonary Vein Ablation for Paroxysmal Atriai 
Fibrillation in a Prospective Multi-Center Study 
Tim Risius Stephan Willems, Stefan G. Spitzer, Claus Schmitt, Thorsten Lewalter, -I 
Berndt Luederitz, University Hospital Hamburg-Eppendori, Hamburg, Germany, 
University of Bonn, Bonn, Germany 
Paroxysmal atrial fibrillation (PAF) is predominantly triggered by focal e&pies located 
within the pulmonary veins (PV). The BITMAP Study (Breakthrough and Isolation Trial: 
Mapping and Ablation of Pulmonary Veins) investigates prospectively the safety and effi- 
cacy of a new catheter with circumferential mapping and ablation electrodes. We report 
the phenomenon of ST-Segment-Elevation during catheter placement in the lefl atrium 
(LA) and superior pulmonary veins in this multi-center study. Methods: 37 pts. (55ill 
years) with recurrent PAF were prospectively included. RFC ablation supported by the 
4F REVELATION Helix microcatheter (Cardima Inc.. USA) with 8 distal electrodes for 
bipolar mapping and ablation targeted a total number of 3+1 PV. RFC was applied at the 
ostial region (max. power 30 W, 45-5O’C) with a maximum of 4 RFC per electrode. All 
patients were adequately anticoaglatad (ACT>250) an continuous ECG-Monitoring was 
performed. Results: In 5 out of 37 pts. from three centers we recorded the occurrence of 
ST-Segment-Elevation >0.2mV and accompanying left thoracic pain. In all 5 cases it was 
attempted to place the guiding catheter near the superior PVs and thus manipulating the 
left dorsal wall of the LA. The ECG changes and the symptoms started abruptly and 
lasted for 5*4 min. Pericardial effusion could instantaneously be excluded by echocar- 
diography in all cases. Coronary angiograms were performed in three pts. with the long- 
est episode, no thrombotic material or air amboli were present. The symptoms and the 
ECG-changes resolved completely in all pts. 
Conclusions The phenomenon of ST-Segment-Elevation during LA- and PV-Mapping 
in pts. with PAF is a common occurrence (13.5 %). In this prospective multi-center trial 
we demonstrated the reversibility of this phenomenon, no cardiovascular or cerebral 
damages were reported during procedure and follow-up. Although the mechanism is still 
unclear, vasospasm due to autonomic dysregulation seems to contribute to this phenom- 
enon, because no evidence for air embolism or embolic material was present. 
1063-17 bstiai Locations of Pulmonary Vein Fasicles in Patients 
With Atriai Fibrillation 
Jihn D. Han, Bradley P. Knight, Christoph Scharf, Aman Chugh, Marcy Yackish. Frank 
Pelosi. Jr., Fred Morady, Hakan Oral, University of Michigan Hospitals, Ann Arbor, Ml 
Background: Segmental ostial applications of radiofrequency energy (RF) have been 
performed to electrically disconnect the pulmonary veins (PV) in patients with atrial fibril- 
lation (AF). 
Objective: To describe the topographic locations of PV fasicles around the circumfer- 
ence of the PV ostia. 
Methods: In 85 consecutive patients with AF, 3-4 PV’s were isolated. Angiograms of the 
PVs were obtained. Segmental ostial ablation guided by ostial PV potentials recorded 
from a circular decapolar catheter was performed with a 4mm-tip catheter. The PV 
ostium was divided into 4 quadrants: superior, inferior, anterior, posterior. Sites of ostial 
RF applications were recorded on an c&al quadrant map. 
Results: A total of 1393 ostial sites were ablated: 515 in the left superior PV (37%). 348 
in the left inferior PV(25%), 465 in the right superior PV (33%), and 65 in the right inferior 
PV(5%). Among 1393 targeted ostial sites, 419 (30%) were in the superior, 373 (26%) in 
the inferior, 337 (24%) in the anterior, and 264 (20%) in the posterior quadrants. There 
were no significant differences in distribution of targeted ostial sites among the Pv’s, 
although the posterior quadrant was targeted less often (Table). 
Conclusions: During a PV isolation, -60% of muscle fasicles are in the superior and 
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inferior quadrants of the PV ostia. These observations underscore the importance of 
complete circumferential mapping of the PV ostia, as PV fasicles may be present in any 
ouadrant. 
LSPV 
RSPV 
LIPV 
RIPV 
Total # 
Superior Anterior 
148 (29%) 144 (26%) 
150 (32%) 84 (16%) 
107 (31%) 98 (28%) 
14 (21%) 11 (17%) 
419 (30%) 337 (24%) 
Interior 
136 (26%) 
138 (30%) 
79 (23%) 
20 (31%) 
373 (26%) 
Posterior 
87 (17%) 
93 (20%) 
64 (18%) 
20 (31%) 
264 (20%) 
Total# 
515 (37%) 
465 (33%) 
348 (25%) 
65 (5%) 
1393 
1063-18 Acute and Long-Term Results of Radiofrequency 
Ablation of Common Atriai Flutter and the influence of I 
the Right Atriai Isthmus Ablation on the Occurrence of 
Atriai Fibrillation I 
Sebastian Schmieder, Gjin Ndrepepa, Jun Dong. Bernhard Zrenner, Juergen Schreieck, 
Michael A. Schneider. lldiko Dobran. Martin R. Karch. Claus Schmitt. Deutsches 
Herzzentrum Munch& & 1. Med. Kljnik der Technischen Universit& Munich, Genany 
Background: The purpose of this study was to evaluate the acute success rate and 
long-term efficacy of radiofrequency ablation of common type atrial fluner (AFL) by using 
a standardized anatomical approach in a large series of patients and to assess the influ- 
ence of right atrial isthmus ablation on the occurrence of atrial fibrillation. There are no 
large scale prospective or retrospective multicenter studies for radiofrequency ablation of 
AFL. 
Methods: The study population consisted of 363 consecutive patients with AFL (mean 
age 58 f 16 years, 265 men) who underwent radiofrequency ablation at the inferior vena 
cava-tricuspid annulus isthmus (IVC-TA) using a standardized anatomic approach. 
Results: Bi-directional isthmus block at the IVC-TA was achieved in 328 patients (90 %). 
Following radiofrequency ablation, 343 patients (95 %) were followed for a mean of 496 * 
335 days. During the follow-up period, 310 patients (90 %) remained free of AFL recur- 
rences. Multivariate analysis identified five independent predictors of AFL recurrence: flu- 
oroscopy time (p<O.OOl), atrial fibrillation after AFL ablation (p = O.Ol), lack of bi- 
directional block (p = 0.02). reduced left ventricular function (p = 0.035) and right atrial 
dimensions (p = 0.046). Atrial fibrillation occurrence was significantly reduced after AFL 
ablation (112 in 343 patients, 33 %) as compared to occurrence of atrial fibrillation before 
radiofrequency ablation (198 in 363 patients, 55 %, p < 0.001). 
Conclusion: The current anatomical ablation approach for AFL and criteria for evalua- 
tion of the IVC-TA isthmus block is associated with an acute success rate of 90 % and a 
long-term recurrence rate of 10 %. Radiofrequency ablation of common AFL results in a 
significant reduction in the occurrence of atrial fibrillation. 
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1064-I A Multicenter Study of Heart Failure as a Predictor for 
internal Cardioverter Defibrillator Shocks 
William Whanq. Murray A. Mittleman, Paul J. Wang, Jennifer C. Merlan, David Rich, 
James E. Muller, Jeremy N. Ruskin. Christine M. Albert, Massachusetts General 
Hospital, Boston, MA 
Bsckgrounct Although left ventricular ejection fraction (LVEF) is a well known predictor 
of device discharges in patients with internal cardioverter-defibrillators (ICDs). the rela- 
tionship between discharges and the presence and severity of congestive heart failure 
(CHF) is less clear. 
Methods: We prospectively examined the relationship between presence and severity of 
CHF symptoms and subsequent risk of ICD discharges for ventricular tachycardialven- 
tricular fibrillation (VTNF) among 861 patients who underwent ICD implantation in the 
Triggers of Ventricular Arrhythmias (TOVA) study. Proportional hazards models were 
used to test for associations prior to and after adjustment for LVEF. 
Results Baseline CHF was present in 357 (41.5%) patients. Df these, 27% had New 
York Heart Assoctation (NYHA) class 1 symptoms, 52% had class 2 symptoms, and 21% 
had class 3 or 4 symptoms. Over an average follow-up of 421 days, 53 patients received 
an arxxorxiata ICD discharae for VTNF. Univariate analvses revealed Dositive associa- 
tion, between baseline CHF and appropriate ICD discharges (RR=l.$7; 95% Cl,l.O3- 
3.041. Darticularlv amona Datients with NYHA class 3 or 4 svmotoms IRR= 2.37: 95% 
I .  I  , .  
CI,l.O3-5.46). However, after controlling for LVEF and other potential confounders, these 
relationships were attenuated, and baseline CHF was no longer associated with future 
appropriate ICD discharge (RR=l.l3,95% Cl, 0.6-2.03). However, the risk of discharges 
remained elevated among patients with NYHA class 3 or 4 (RR=l.89, 95% Cl,O.77-4.65), 
but the association was not statistically significant (p=O.17). 
Conclusiolr In these prospective data, after controlling for LVEF. the presence of CHF 
